Skip to content

Drug interactions

Exemestane + Lorlatinib

Severity: Moderate

Exemestane and Lorlatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lorlatinib is a moderate CYP3A inducer and may decrease exemestane levels, potentially reducing its efficacy.

What this interaction means in plain words

Exemestane and Lorlatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Exemestane belongs to Oncology; Lorlatinib belongs to Oncology.

Evidence level: Low

Why it happens

Lorlatinib induces CYP3A4, increasing exemestane metabolism.

What to do

Monitor for diminished response; consider exemestane 50 mg daily if a potent inducer effect is suspected.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Exemestane and Lorlatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Exemestane with Lorlatinib?

MediHelp rates the interaction as moderate. Exemestane and Lorlatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lorlatinib is a moderate CYP3A inducer and may decrease exemestane levels, potentially reducing its efficacy.

How serious is the interaction between Exemestane and Lorlatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for diminished response; consider exemestane 50 mg daily if a potent inducer effect is suspected.

What other medicines interact with Exemestane?

MediHelp also lists interactions of Exemestane with, for example, Bazedoxifene-conjugated estrogens, Desogestrel-ethinyl estradiol, Estradiol. The full list is on the Exemestane page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in